[2-methoxy-4-[(Z)-[5-oxo-2-phenyl-1-(4-sulfamoylphenyl)imidazol-4-ylidene]methyl]phenyl] benzoate

ID: ALA5276096

Chembl Id: CHEMBL5276096

Max Phase: Preclinical

Molecular Formula: C30H23N3O6S

Molecular Weight: 553.60

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(/C=C2\N=C(c3ccccc3)N(c3ccc(S(N)(=O)=O)cc3)C2=O)ccc1OC(=O)c1ccccc1

Standard InChI:  InChI=1S/C30H23N3O6S/c1-38-27-19-20(12-17-26(27)39-30(35)22-10-6-3-7-11-22)18-25-29(34)33(28(32-25)21-8-4-2-5-9-21)23-13-15-24(16-14-23)40(31,36)37/h2-19H,1H3,(H2,31,36,37)/b25-18-

Standard InChI Key:  UAPDIEQHDVVWQH-BWAHOGKJSA-N

Alternative Forms

  1. Parent:

    ALA5276096

    ---

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 553.60Molecular Weight (Monoisotopic): 553.1308AlogP: 4.40#Rotatable Bonds: 7
Polar Surface Area: 128.36Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.13CX Basic pKa: CX LogP: 4.87CX LogD: 4.87
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.21Np Likeness Score: -0.93

References

1. Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K..  (2022)  Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors.,  13  (5.0): [PMID:35685617] [10.1039/d1md00280e]

Source